Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.605,92
0,63%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TELA Bio Inc (TELA) TELA Bio Inc (TELA) Notizie

TELA Bio Inc

TELA
5,36
-0,17 (-3,07%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/6/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:55EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/6/202422:15EDGAR2Form 8-K - Current report
04/6/202422:05GLOBETELA Bio Appoints Jeffrey Blizard to its Board of Directors
20/5/202422:15EDGAR2Form 8-K - Current report
20/5/202422:03GLOBETELA Bio Appoints Greg Firestone as Chief Commercial Officer
10/5/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
09/5/202422:20EDGAR2Form 8-K - Current report
09/5/202422:05GLOBETELA Bio Reports First Quarter 2024 Financial Results
25/4/202413:00GLOBETELA Bio to Announce First Quarter 2024 Financial Results
15/4/202413:00GLOBETELA Bio Announces U.S. Commercial Launch of..
08/4/202413:00GLOBETELA Bio Welcomes Acclaimed Surgeon as Vice President of..
21/3/202421:05GLOBETELA Bio Achieves Record Fourth Quarter and Full Year 2023..
21/3/202412:00GLOBETELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the..
20/3/202412:00GLOBETELA Bio Announces Sale of Distribution Rights for Wound..
29/2/202413:00GLOBETELA Bio to Announce Fourth Quarter and Full Year 2023..
27/2/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:05EDGAR2Form 3/A - Initial statement of beneficial ownership of..
14/2/202423:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202412:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19/1/202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
15/12/202322:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
07/12/202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202313:00GLOBETELA Bio to Take Part in Connecting the Dots
16/11/202313:00GLOBETELA Bio to Participate in Piper Sandler’s 35th Annual..
15/11/202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:44EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202322:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
09/11/202322:05GLOBETELA Bio Reports Third Quarter 2023 Financial Results
26/10/202313:00GLOBETELA Bio to Announce Third Quarter 2023 Financial Results
20/10/202322:06EDGAR2Form 8-K - Current report
06/10/202317:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/9/202322:05EDGAR2Form 8-K - Current report
18/9/202322:05GLOBETELA Bio to Participate in the Gilmartin Group Emerging..
16/8/202313:15EDGAR2Form 8-K - Current report
16/8/202313:00GLOBETELA Bio Announces U.S. Commercial Launch of OviTex® PRS..
10/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:05EDGAR2Form 8-K - Current report
09/8/202322:03GLOBETELA Bio Reports Second Quarter 2023 Financial Results
04/8/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 5,49 Min: 5,25 Max: 5,49
Chiusura: 5,53

La tua Cronologia

NASDAQ
TELA
TELA Bio
COIN
GMXUSD
GMX
BIT
I09241
Intesa Sanpaolo
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network